Arjun Rallapalli, PhD

Arjun Rallapalli is focused on developing Evozyne’s overall strategy by identifying new markets, solutions, and services for the company’s proprietary technology and implementing the strategy through business development and partnerships. Before Evozyne, Rallapalli was a manager at McKinsey & Company, where he led strategy engagements across different sectors. He began his career at GE Healthcare before obtaining a PhD in electrical engineering at Duke University where he explored the possibility of creating photonic logic devices using DNA and organic molecules.